LADENBURG THALMANN FINANCIAL SERVICES INC. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$237,0000.0%14,9490.0%0.00%0.0%
Q1 2018$237,000
-21.5%
14,949
+2.5%
0.00%
-33.3%
Q4 2017$302,000
+64.1%
14,583
+13.7%
0.00%
+50.0%
Q3 2017$184,000
-46.8%
12,824
-35.9%
0.00%
-50.0%
Q2 2017$346,000
+21.4%
20,008
-22.8%
0.00%0.0%
Q1 2017$285,000
-23.0%
25,908
+3.4%
0.00%
-20.0%
Q4 2016$370,000
-24.2%
25,055
+26.4%
0.01%
-28.6%
Q3 2016$488,000
+19.3%
19,825
-2.0%
0.01%0.0%
Q2 2016$409,000
+6.0%
20,226
+41.1%
0.01%0.0%
Q1 2016$386,000
-66.4%
14,336
+26.1%
0.01%
-66.7%
Q4 2015$1,149,000
-47.1%
11,367
-6.6%
0.02%
-53.3%
Q3 2015$2,172,000
-4.1%
12,174
+19.7%
0.04%
+7.1%
Q2 2015$2,266,000
+23.4%
10,170
+9.9%
0.04%
+20.0%
Q1 2015$1,837,000
+71.4%
9,256
+27.1%
0.04%
+45.8%
Q4 2014$1,072,000
+71.2%
7,284
+52.5%
0.02%
+41.2%
Q3 2014$626,000
-7.0%
4,775
-10.5%
0.02%
-5.6%
Q2 2014$673,000
-70.2%
5,334
-68.9%
0.02%
-72.7%
Q1 2014$2,259,000
-20.0%
17,130
-29.0%
0.07%
-24.1%
Q4 2013$2,825,000
+13.5%
24,123
+1.2%
0.09%
+3.6%
Q3 2013$2,490,000
+32.5%
23,847
+9.8%
0.08%
+25.4%
Q2 2013$1,879,00021,7150.07%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2017
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders